Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00517361
Status:
TERMINATED
Last Update Posted:
2014-04-15
First Post:
2007-08-14
Brief Title:
Phase II Study of Carboplatin and Bevacizumab Avastin for ER Neg PR Neg and HER2Neu Neg Metastatic Breast Cancer
Sponsor:
University of Chicago
Organization:
University of Chicago
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-08-14
First Submit QC Date:
August 14 2007
Study First Post Date:
2007-08-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-04-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-03-10
Last Update Post Date:
2014-04-15
Last Update Post Date Type:
ESTIMATED